Patrice Rioux serves as Executive at Raptor Pharmaceutical Corp, where they oversee executive responsibilities. Since joining the company, Patrice Rioux has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 1, 2026 involved receiving (via award) 2,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 1, 2026 | MNPR | $0 | Award | 2,000 | $N/A | Discretionary |
| Nov 26, 2019 | NONE | $110.0K | Option Exercise | 18,333 |
Patrice Rioux currently holds 2,000 shares of Raptor Pharmaceutical Corp (RPTP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Patrice Rioux has been a net neutral trader of RPTP stock. They have purchased $0 and sold $0 worth of shares.
Patrice Rioux's most recent insider trade was on Jan 1, 2026, when they sold 2,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.00 |
| Discretionary |
| Nov 26, 2019 | NONE | $0 | Option Exercise | 100 | $N/A | Discretionary |
| Apr 13, 2012 | RPTP | $21.7K | Option Exercise | 25,497 | $0.85 | Discretionary |